Assistant Professor in Medicine, Massachusetts General Hospital
Oncology
Dr. Ephraim P. Hochberg, MD
|
|
Give Review
Ephraim Hochberg practices Oncology. He studied medicine at Case Western Reserve University School of Medicine. He received awards:"America's Top Doctors", "Boston Magazine", "America's Top Doctors for Cancer" and "Super Doctor". Ephraim Hochberg is a published doctor. He has 60 papers published. The most current publication "Interleukin-2 (IL-2) receptor alpha, beta and gamma subunit expression as a function of B-cell lineage ontogeny: the use of IL-2-PE66(4Glu) to characterize internaliza..." He is registered with Medicare.
Publications
- Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem Cell transpl...
- Lichenoid Mucosal Reaction to Rituximab.
- A Man with Paraneoplastic Retinopathy plus Small Fiber Polyneuropathy Associated with Waldenström Macroglobulinemia (Lymphoplasmacytic Lymphoma): Insights into Mechani...
- Automatic Lymphoma classification with sentence subgraph mining from pathology reports.
- A targeted mutational landscape of angioimmunoblastic T cell Lymphoma.
- Treatment of primary mediastinal B-cell Lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary re...
- Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell Lymphoma.
- Jaundice six months following Liver transplantation.
- HHV8-Negative Primary Effusion Lymphoma of B-Cell Lineage: Two Cases and a Comprehensive Review of the Literature.
- Oral clofarabine for relapsed/refractory non-Hodgkin Lymphomas: results of a phase 1 study.
- Pediatric-type nodal follicular Lymphoma: an indolent clonal proliferation in children and adults, with high proliferation index and no BCL2 rearrangement.
- Hodgkin Lymphoma.
- Patient Death Attributable to Implant-Related Primary Anaplastic Large Cell Lymphoma of the Breast: A Case Report and Review of the Literature.
- Autologous stem cell transplantation with thiotepa, busulfan and cyclophosphamide (tbc) conditioning in patients with cns involvement by non-hodgkin Lymphoma.
- Enteropathy-associated T-cell Lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project.
- Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
- Novel diagnostic approaches in bing-neel syndrome.
- Intravenous methotrexate as central Nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell ly...
- Orbital involvement in Bing-Neel syndrome.
- Surveillance imaging of Hodgkin Lymphoma patients in first remission: a clinical and economic analysis.
- B-cell Lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt Lymphoma and diff...
- Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma: a single-institution exp...
- Bing-Neel Syndrome revisited.
- Bleomycin-induced flagellate erythema.
- Case records of the Massachusetts General Hospital. Case 17-2006--a 34-year-old man with cavitary Lung lesions.
- Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays.
- Low histologic grade follicular Lymphoma with high proliferation index: morphologic and clinical features.
- Antibody responses to H-Y minor histocompatibility antigens correlate with Chronic graft-versus-host disease and disease remission.
- Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous Leukemia relapse after allogeneic transplantation: durable cytogenetic ...
- Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem Cell transplantation and in healthy female donors.
- Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host Disease prophylaxis in mismatched related donor or unrelated donor transplantation.
- A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem Cell transplantation.
- Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T Cells with cytolytic activity directed against recipient hematopoietic Cells.
- Baseline total lesion glycolysis measured with (18)F-FDG PET/CT as a predictor of progression-free survival in diffuse large B-cell Lymphoma: a pilot study.
- A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL.
- Renal aspergilloma: an unusual cause of infection in a patient with the acquired immunodeficiency syndrome.
- Interleukin-2 (IL-2) receptor alpha, beta and gamma subunit expression as a function of B-Cell lineage ontogeny: the use of IL-2-PE66(4Glu) to characterize internaliza...
- Bladder rupture associated with pelvic fracture due to blunt trauma.
- Ocular distribution of the chimeric protein IL2-PE40.
- Quantitative monitoring of BCR/ABL transcript during STI-571 therapy.
- Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host Disease associated with donor lymphocyte infusion.
- Safety and efficacy of denileukin diftitox in patients with steroid-refractory Acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
- Sirolimus and tacrolimus without methotrexate as graft-versus-host Disease prophylaxis after matched related donor peripheral blood stem cell transplantation.
- Molecular assessment of erythroid lineage chimerism following nonmyeloablative allogeneic stem Cell transplantation.
- Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple Myeloma.
- Quantitation of T-Cell neogenesis in vivo after allogeneic bone marrow transplantation in adults.
- Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host Disease.
- Chemotherapy is an effective first line treatment for early stage gastric mucosa-associated lymphoid tissue Lymphoma.
- Intravascular Lymphoma: the oncologist's "great imitator".
- Primary CNS Lymphoma.
- Neurological manifestations of Waldenström Macroglobulinemia.
- Primary effusion Lymphoma.
- Characteristics and outcomes after autologous stem cell transplant for patients with relapsed or refractory diffuse large B-cell Lymphoma who failed initial rituximab,...
- Rare lymphoid malignancies of the Breast: a report of two cases illustrating potential diagnostic pitfalls.
- Carcinoma and multiple Lymphomas in one patient: establishing the diagnoses and analyzing risk factors.
- Monotherapy with methotrexate for primary central Nervous lymphoma has single agent activity in the absence of radiotherapy: a single institution cohort.
- Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt''s Lymphoma: a retrospective analysis.
- End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin''s Lymphoma.
- Current Status of Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma.
Schools
Case Western Reserve University School of Medicine
Brigham and Women39s Hospital
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- America's Top Doctors for Cancer
- Super Doctor
Education
-
Brigham and Women's Hospital -
Case Western Reserve University School of Medicine
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1326038407 | |
| NPPES Provider LastName | HOCHBERG | |
| NPPES Provider FirstName | EPHRAIM | |
| NPPES Provider ZIPCode | 021142621 | |
| NPPES Provider State | MA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 90.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326038407 |
| Last Name Of The Provider | HOCHBERG |
| First Name Of The Provider | EPHRAIM |
| View All |
Similar Doctors
|
|
Dr. Daria V. Babushok, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wei Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Sheheryar K. Kabraji, MB CHB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew S. Paulson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jon E. Arnason, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Xiaosong Zhang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald W. Takvorian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James W. Mier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen A. Cannistra, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Leroy M. Parker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Hassett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eddy J. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rameen Beroukhim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eliezer M. VanAllen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lowell E. Schnipper, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Anupam M. Desai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas A. Abrams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kellie Sprague, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David P. Schenkein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sujung Park, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roxanne J. Wadia, MD
This Doctor is OpenDoctor Recommended.
|